ACUTE ARTERIAL THROMBOSIS IN A PATIENT WITH BREAST-CANCER AFTER CHEMOTHERAPY WITH 5-FLUOROURACIL, DOXORUBICIN, LEUCOVORIN, CYCLOPHOSPHAMIDE, AND INTERLEUKIN-3
C. Theodossiou et al., ACUTE ARTERIAL THROMBOSIS IN A PATIENT WITH BREAST-CANCER AFTER CHEMOTHERAPY WITH 5-FLUOROURACIL, DOXORUBICIN, LEUCOVORIN, CYCLOPHOSPHAMIDE, AND INTERLEUKIN-3, Cancer, 74(10), 1994, pp. 2808-2810
Background. Interleukin-3 (IL-3) is an experimental agent used to amel
iorate neutropenia in patients receiving chemotherapy. Arterial thromb
otic episodes after use of IL-3 have not been reported previously. Met
hods. The case of a patient with Stage III adenocarcinoma of the breas
t who developed hypotension and acute cerebellar artery and superior m
esenteric artery thrombosis after receiving chemotherapy and treatment
with IL-3 is reported. Results. To the authors' knowledge, this is th
e first patient with arterial thrombosis reported after treatment with
IL-3. Conclusions. Interleukin-5 may be associated with increased pro
pensity for thrombosis.